How to Manage Your Costs With the Recent Weight-Loss Drug Hype

Ozempic and other weight-loss drugs have been fueling a recent widespread craze that impacts plans across the country. One problem with the craze is that because these are new drugs, we are still learning of possible serious side effects. Safety concerns are growing and under investigation. Plus, a positive impact on overall health is not yet proven. But importantly, some patients are experiencing remarkable results. In the face of the demand for these drugs, employers need a plan for managing cost growth and determining the most clinically valid coverage policies.

In this presentation, you will learn:

• What we know about how well these drugs work compared to each other

• Important safety concerns and the plan to evaluate them

• The results of two case studies exploring how employers have navigated balancing coverage and cost.

​This webcast is part of a Health Benefits Conference & Expo (HBCE) series, serving as a sample of the content being presented at the 2024 conference. Please check out hbce.com for more information on the conference and more content like this.